Ateka Gunja1,2, Maggie A Stanislawski3, Anna E Barón3,4,5,6, Thomas M Maddox7, Steven M Bradley5,8, Mladen I Vidovich1,2. 1. Division of Cardiology, University of Illinois at Chicago. 2. Division of Cardiology, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois. 3. University of Colorado School of Medicine, Aurora. 4. Colorado CV Health Care System, Denver, Colorado. 5. Veterans Affairs Eastern Colorado Health Care System, Denver, Colorado. 6. Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora. 7. Division of Cardiology, Washington University School of Medicine, St. Louis, Missouri. 8. Minneapolis Heart Institute, Center for Healthcare Delivery Innovation, and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota (work completed while at VA Eastern Colorado Health Care System).
Abstract
BACKGROUND: Cocaine use has been associated with adverse cardiovascular outcomes in patients with coronary artery disease (CAD). It is unclear whether this is due to direct effects of cocaine or other factors. HYPOTHESIS: Cocaine use is associated with worse outcomes in patients undergoing cardiac catheterization METHODS: We used the Veterans Affairs database to identify veterans undergoing coronary catheterization between 2007 and 2014. We analyzed association between cocaine use and 1-year all-cause mortality, myocardial infarction (MI), and cerebrovascular accident (CVA) among veterans with obstructive CAD (N = 122 035). To explore factors contributing to these associations, we sequentially adjusted for cardiac risk factors, risky behaviors, and clinical conditions directly affected by cocaine. RESULTS: 3082 (2.5%) veterans were cocaine users. Cocaine users were younger (median 58.2 vs 65.3 years; P < 0.001), more likely to be African American (58.9% vs 10.6%; P < 0.001), and had fewer traditional cardiac risk factors. After adjustment for cardiac risk factors, cocaine was associated with increased risk of mortality (HR: 1.23, 95% CI: 1.08-1.39), MI (HR: 1.40, 95% CI: 1.07-1.83), and CVA (HR: 1.88, 95% CI: 1.38-2.57). With continued adjustment, increased CVA risk remained significantly associated with cocaine use, whereas MI risk was mediated by risky behaviors and mortality was fully explained by conditions directly affected by cocaine. CONCLUSIONS: Cocaine use is associated with adverse cardiac events in veterans with CAD. Contributors to this association are multifaceted and specific to individual cardiovascular outcomes, including associated risky behaviors and direct effects of cocaine. Effective intervention programs to reduce cardiac events in this population will require multiple components addressing these factors.
BACKGROUND:Cocaine use has been associated with adverse cardiovascular outcomes in patients with coronary artery disease (CAD). It is unclear whether this is due to direct effects of cocaine or other factors. HYPOTHESIS: Cocaine use is associated with worse outcomes in patients undergoing cardiac catheterization METHODS: We used the Veterans Affairs database to identify veterans undergoing coronary catheterization between 2007 and 2014. We analyzed association between cocaine use and 1-year all-cause mortality, myocardial infarction (MI), and cerebrovascular accident (CVA) among veterans with obstructive CAD (N = 122 035). To explore factors contributing to these associations, we sequentially adjusted for cardiac risk factors, risky behaviors, and clinical conditions directly affected by cocaine. RESULTS: 3082 (2.5%) veterans were cocaine users. Cocaine users were younger (median 58.2 vs 65.3 years; P < 0.001), more likely to be African American (58.9% vs 10.6%; P < 0.001), and had fewer traditional cardiac risk factors. After adjustment for cardiac risk factors, cocaine was associated with increased risk of mortality (HR: 1.23, 95% CI: 1.08-1.39), MI (HR: 1.40, 95% CI: 1.07-1.83), and CVA (HR: 1.88, 95% CI: 1.38-2.57). With continued adjustment, increased CVA risk remained significantly associated with cocaine use, whereas MI risk was mediated by risky behaviors and mortality was fully explained by conditions directly affected by cocaine. CONCLUSIONS:Cocaine use is associated with adverse cardiac events in veterans with CAD. Contributors to this association are multifaceted and specific to individual cardiovascular outcomes, including associated risky behaviors and direct effects of cocaine. Effective intervention programs to reduce cardiac events in this population will require multiple components addressing these factors.
Authors: Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos Journal: Lancet Date: 2013-08-29 Impact factor: 79.321
Authors: James Brian Byrd; Rebecca Vigen; Mary E Plomondon; John S Rumsfeld; Tamára L Box; Stephan D Fihn; Thomas M Maddox Journal: Am Heart J Date: 2013-01-19 Impact factor: 4.749
Authors: Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Henry H Ting; Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Ralph G Brindis; Donald E Casey; Mina K Chung; James A de Lemos; Deborah B Diercks; James C Fang; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao; Jonathan L Halperin; Glenn N Levine; Jeffrey L Anderson; Nancy M Albert; Sana M Al-Khatib; Kim K Birtcher; Biykem Bozkurt; Ralph G Brindis; Joaquin E Cigarroa; Lesley H Curtis; Lee A Fleisher; Federico Gentile; Samuel Gidding; Mark A Hlatky; John Ikonomidis; Jose Joglar; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Duminda N Wijeysundera Journal: Catheter Cardiovasc Interv Date: 2016-05 Impact factor: 2.692
Authors: Melissa M Farmer; Maggie A Stanislawski; Mary E Plomondon; Bevanne Bean-Mayberry; Nataria T Joseph; Lauren E Thompson; Jessica L Zuchowski; Stacie L Daugherty; Elizabeth M Yano; P Michael Ho Journal: J Womens Health (Larchmt) Date: 2017-05-12 Impact factor: 2.681
Authors: Lloyd W Klein; Peter Block; Ralph G Brindis; Charles R McKay; Ben D McCallister; Michael Wolk; William Weintraub Journal: J Am Coll Cardiol Date: 2002-08-07 Impact factor: 24.094
Authors: J E Hollander; K H Todd; G Green; K L Heilpern; D J Karras; A J Singer; G X Brogan; J P Funk; J B Strahan Journal: Ann Emerg Med Date: 1995-12 Impact factor: 5.721
Authors: Ateka Gunja; Maggie A Stanislawski; Anna E Barón; Thomas M Maddox; Steven M Bradley; Mladen I Vidovich Journal: Clin Cardiol Date: 2018-06-09 Impact factor: 2.882